Bone Regeneration in Inflammation with Aging and Cell-based Immunomodulatory Therapy

Overview

Journal Inflamm Regen

Publisher Biomed Central

Date 2023 May 25

PMID 37231450

Authors

Junichi Kushioka

Simon Kwoon-Ho Chow

Masakazu Toya

Masanori Tsubosaka

Huaishuang Shen

Qi Gao

Xueping Li

Ning Zhang

Stuart B Goodman

Affiliations

Soon will be listed here.

Abstract

Aging of the global population increases the incidence of osteoporosis and associated fragility fractures, significantly impacting patient quality of life and healthcare costs. The acute inflammatory reaction is essential to initiate healing after injury. However, aging is associated with "inflammaging", referring to the presence of systemic low-level chronic inflammation. Chronic inflammation impairs the initiation of bone regeneration in elderly patients. This review examines current knowledge of the bone regeneration process and potential immunomodulatory therapies to facilitate bone healing in inflammaging.Aged macrophages show increased sensitivity and responsiveness to inflammatory signals. While M1 macrophages are activated during the acute inflammatory response, proper resolution of the inflammatory phase involves repolarizing pro-inflammatory M1 macrophages to an anti-inflammatory M2 phenotype associated with tissue regeneration. In aging, persistent chronic inflammation resulting from the failure of M1 to M2 repolarization leads to increased osteoclast activation and decreased osteoblast formation, thus increasing bone resorption and decreasing bone formation during healing.Inflammaging can impair the ability of stem cells to support bone regeneration and contributes to the decline in bone mass and strength that occurs with aging. Therefore, modulating inflammaging is a promising approach for improving bone health in the aging population. Mesenchymal stem cells (MSCs) possess immunomodulatory properties that may benefit bone regeneration in inflammation. Preconditioning MSCs with pro-inflammatory cytokines affects MSCs' secretory profile and osteogenic ability. MSCs cultured under hypoxic conditions show increased proliferation rates and secretion of growth factors. Resolution of inflammation via local delivery of anti-inflammatory cytokines is also a potential therapy for bone regeneration in inflammaging. Scaffolds containing anti-inflammatory cytokines, unaltered MSCs, and genetically modified MSCs can also have therapeutic potential. MSC exosomes can increase the migration of MSCs to the fracture site and enhance osteogenic differentiation and angiogenesis.In conclusion, inflammaging can impair the proper initiation of bone regeneration in the elderly. Modulating inflammaging is a promising approach for improving compromised bone healing in the aging population.

Citing Articles

Preclinical study of engineering MSCs promoting diabetic wound healing and other inflammatory diseases through M2 polarization.

Wu D, Liu R, Cen X, Dong W, Chen Q, Lin J Stem Cell Res Ther. 2025; 16(1):113.

PMID: 40038782 PMC: 11881511. DOI: 10.1186/s13287-025-04248-y.

Crosstalk Between H-Type Vascular Endothelial Cells and Macrophages: A Potential Regulator of Bone Homeostasis.

Fan J, Xie Y, Liu D, Cui R, Zhang W, Shen M J Inflamm Res. 2025; 18:2743-2765.

PMID: 40026304 PMC: 11871946. DOI: 10.2147/JIR.S502604.

Protective Effect of Methyl Sulfonyl Methane on the Progression of Age-Induced Bone Loss by Regulating Oxidative Stress-Mediated Bone Resorption.

Zhang D, Wang L, Tang L, Zhang Y, Zhang H, Zou L Antioxidants (Basel). 2025; 14(2).

PMID: 40002402 PMC: 11851857. DOI: 10.3390/antiox14020216.

Primed Mesenchymal Stem Cells by IFN-γ and IL-1β Ameliorate Acute Respiratory Distress Syndrome through Enhancing Homing Effect and Immunomodulation.

Kong T, Seo S, Han Y, Seo W, Kim B, Kim J Biomol Ther (Seoul). 2025; 33(2):311-324.

PMID: 39973472 PMC: 11893491. DOI: 10.4062/biomolther.2025.004.

Nonlinear association between liver fat content and lumbar bone mineral density in overweight and obese individuals: evidence from a large-scale health screening data in China.

Liu A, Sun Y, Qi X, Zhou Y, Zhou J, Li Z Endocrine. 2025; .

PMID: 39869295 DOI: 10.1007/s12020-025-04168-0.

References

Ginhoux F, Schultze J, Murray P, Ochando J, Biswas S . New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol. 2015; 17(1):34-40. DOI: 10.1038/ni.3324. View

Huang H, Kim H, Chang E, Lee Z, Hwang S, Kim H . IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 2009; 16(10):1332-43. DOI: 10.1038/cdd.2009.74. View

Franceschi C, Campisi J . Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014; 69 Suppl 1:S4-9. DOI: 10.1093/gerona/glu057. View

Liu W, Li L, Rong Y, Qian D, Chen J, Zhou Z . Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 2019; 103:196-212. DOI: 10.1016/j.actbio.2019.12.020. View

Gerstenfeld L, Cho T, Kon T, Aizawa T, Cruceta J, Graves B . Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs. 2001; 169(3):285-94. DOI: 10.1159/000047893. View

Burrello J, Monticone S, Gai C, Gomez Y, Kholia S, Camussi G . Stem Cell-Derived Extracellular Vesicles and Immune-Modulation. Front Cell Dev Biol. 2016; 4:83. PMC: 4992732. DOI: 10.3389/fcell.2016.00083. View

Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts A . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2(2):141-50. DOI: 10.1016/j.stem.2007.11.014. View

English K . Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol. 2012; 91(1):19-26. DOI: 10.1038/icb.2012.56. View

Lee J, Park J, Kim T, Jung B, Lee Y, Shim E . Human bone marrow stem cells cultured under hypoxic conditions present altered characteristics and enhanced in vivo tissue regeneration. Bone. 2015; 78:34-45. DOI: 10.1016/j.bone.2015.04.044. View

10.

Crisostomo P, Wang Y, Markel T, Wang M, Lahm T, Meldrum D . Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008; 294(3):C675-82. DOI: 10.1152/ajpcell.00437.2007. View

11.

Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon I, Nepomnaschy I . Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010; 5(2):e9252. PMC: 2821929. DOI: 10.1371/journal.pone.0009252. View

12.

Stranks A, Hansen A, Panse I, Mortensen M, Ferguson D, Puleston D . Autophagy Controls Acquisition of Aging Features in Macrophages. J Innate Immun. 2015; 7(4):375-91. PMC: 4386145. DOI: 10.1159/000370112. View

13.

Bastian O, Pillay J, Alblas J, Leenen L, Koenderman L, Blokhuis T . Systemic inflammation and fracture healing. J Leukoc Biol. 2011; 89(5):669-73. DOI: 10.1189/jlb.0810446. View

14.

Noh M . Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells. Biochem Pharmacol. 2011; 83(5):661-70. DOI: 10.1016/j.bcp.2011.12.010. View

15.

Becker D, Kilgore M, Morrisey M . The societal burden of osteoporosis. Curr Rheumatol Rep. 2010; 12(3):186-91. DOI: 10.1007/s11926-010-0097-y. View

16.

Kumagai K, Vasanji A, Drazba J, Butler R, Muschler G . Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res. 2007; 26(2):165-75. DOI: 10.1002/jor.20477. View

17.

Zhang Y, Hao Z, Wang P, Xia Y, Wu J, Xia D . Exosomes from human umbilical cord mesenchymal stem cells enhance fracture healing through HIF-1α-mediated promotion of angiogenesis in a rat model of stabilized fracture. Cell Prolif. 2019; 52(2):e12570. PMC: 6496165. DOI: 10.1111/cpr.12570. View

18.

Kushioka J, Toya M, Shen H, Hirata H, Zhang N, Huang E . Therapeutic effects of MSCs, genetically modified MSCs, and NFĸB-inhibitor on chronic inflammatory osteolysis in aged mice. J Orthop Res. 2022; 41(5):1004-1013. PMC: 9971358. DOI: 10.1002/jor.25434. View

19.

Al-Qtaitat A, Shore R, Aaron J . Structural changes in the ageing periosteum using collagen III immuno-staining and chromium labelling as indicators. J Musculoskelet Neuronal Interact. 2010; 10(1):112-23. View

20.

Pignolo R, Suda R, McMillan E, Shen J, Lee S, Choi Y . Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell. 2007; 7(1):23-31. PMC: 2394673. DOI: 10.1111/j.1474-9726.2007.00350.x. View